Metanovas Biotech
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-driven biotech developing metabolic reprogramming biologics to target aging and related diseases.
Metabolic DisordersAge-related Diseases
Technology Platform
An AI-powered platform that analyzes metabolic networks to identify novel targets for biologic drugs aimed at reprogramming cellular metabolism.
Opportunities
Addressing the vast and growing market for diseases of aging with a potentially disease-modifying, platform-based approach.
Risk Factors
High scientific risk associated with novel metabolic targets and the complexity of developing effective biologic therapies.
Competitive Landscape
Operates in the competitive longevity biotech space, with rivals like Calico and Unity Biotechnology, but with a distinct AI-metabolic focus for biologics development.